Feiba

Product manufactured by Baxalta Incorporated

Application Nr Approved Date Route Status External Links
BLA101447 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage Feiba Is An Anti-Inhibitor Coagulant Complex Indicated For Use In Hemophilia A And B Patients With Inhibitors For: Control And Prevention Of Bleeding Episodes Perioperative Management Routine Prophylaxis To Prevent Or Reduce The Frequency Of Bleeding Episodes. Feiba Is Not Indicated For The Treatment Of Bleeding Episodes Resulting From Coagulation Factor Deficiencies In The Absence Of Inhibitors To Coagulation Factor Viii Or Coagulation Factor Ix. Feiba Is An Anti-Inhibitor Coagulant Complex Indicated For Use In Hemophilia A And B Patients With Inhibitors For: Control And Prevention Of Bleeding Episodes. Perioperative Management. Routine Prophylaxis To Prevent Or Reduce The Frequency Of Bleeding Episodes. Feiba Is Not Indicated For The Treatment Of Bleeding Episodes Resulting From Coagulation Factor Deficiencies In The Absence Of Inhibitors To Factor Viii Or Factor Ix. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Anti-Inhibitor Coagulant Complex

Comments